iRhythm Technologies, Inc.
iRhythm Technologies (IRTC) develops and operates the Zio ambulatory electrocardiogram (ECG) service: a wearable patch and cloud-based analytics that detect cardiac arrhythmias. Investors should know the business mixes device sales with recurring diagnostic and analytics revenue, giving exposure to both one-off volume and higher-margin service economics. Growth has been driven by broader use of remote cardiac monitoring, partnerships with providers, and improved AI-driven interpretation. Key risks include reimbursement pressure, regulatory scrutiny, competition from other wearables and implantable monitors, and dependence on physician adoption. Profitability has varied as the company invested in scaling operations and product development. For longer-term investors, the case rests on continued clinical adoption, stable reimbursement, and execution on margin expansion. This summary is general educational information, not personalised investment advice; values can rise and fall and past performance is not a reliable guide.
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying iRhythm's stock, indicating they expect it to rise in value.
Financial Health
iRhythm is successfully generating strong revenue and cash flow, indicating good financial performance.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Baskets Featuring IRTC
Wearable Health Stocks: Growth Potential vs Competition
Apple's recent FDA clearance for its Apple Watch hypertension feature marks a major step in wearable medical technology. This development opens up investment opportunities in the broader ecosystem of connected health devices and remote patient monitoring services.
Published: September 12, 2025
Explore BasketAt-Home Healthcare Stocks Explained | FDA Approval
The FDA's approval of an injectable, at-home version of Eisai and Biogen's Alzheimer's drug simplifies treatment and reduces the need for hospital visits. This development highlights a broader trend toward at-home care, creating potential investment opportunities in companies that provide related medical devices and healthcare services.
Published: August 30, 2025
Explore BasketWearable Tech IP Wars: What Investors Should Know
Masimo's lawsuit against U.S. Customs, following a reversal of an import ban on Apple Watches, highlights the fierce competition over intellectual property in wearable health. This theme focuses on the medical technology companies and competitors poised to benefit from the ongoing patent battles in the lucrative health-monitoring device market.
Published: August 21, 2025
Explore BasketHealthcare's Efficiency Imperative
UnitedHealth Group's recent profit miss, driven by high medical costs, has triggered a major cost-cutting initiative across the company. This move signals a broader industry trend, creating an investment opportunity in companies that provide AI and technology solutions to help healthcare organizations improve efficiency and reduce operational expenses.
Published: July 30, 2025
Explore BasketHealthcare's Compliance Catalyst
The Department of Justice's investigation into UnitedHealth's billing practices is increasing pressure on the entire healthcare industry to ensure compliance. This regulatory focus creates an investment opportunity in companies that provide specialized technology for transparent and accurate medical billing.
Published: July 26, 2025
Explore BasketWhy You’ll Want to Watch This Stock
Wearable ECG Leader
Zio’s patch and analytics create a recognised monitoring service; recurring diagnostic revenue is a notable feature, though future returns depend on continued adoption and reimbursement.
Clinical Adoption Trends
Remote monitoring and guideline support could expand use across healthcare systems, yet slower uptake or reimbursement shifts would weigh on revenue.
Competition & Tech
AI-driven interpretation and product improvements are advantages, but competition from wearables and implantables presents execution and margin risks.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Abbott Laboratories
Abbott Laboratories is a global healthcare company that develops and markets a broad range of health care products, including medical devices, diagnostics, nutritionals, and branded generic pharmaceuticals.
Agilent Technologies Inc.
Agilent Technologies, Inc. specializes in life sciences, diagnostics and applied markets, providing application-focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. Its segments include Life Sciences and Diagnostics Markets, Agilent CrossLab and Applied Markets. Life Sciences and Diagnostics Markets segment comprises seven areas of activity. It offers active pharmaceutical ingredients for oligo-based therapeutics as well as solutions that include reagents, instruments, software and consumables. Agilent CrossLab segment offers a services and consumables portfolio that spans the entire lab, in addition to software and laboratory automation solutions, which are designed to enhance customer outcomes. Applied Markets segment offers application-focused solutions that include instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products.
Align Technology Inc.
Align Technology is a medical device company that designs, manufactures and markets a range of dental and orthodontic products.
